AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.595
-0.005 (-0.19%)
Apr 25, 2025, 12:31 PM EDT - Market open
AbCellera Biologics Employees
AbCellera Biologics had 596 employees as of December 31, 2024. The number of employees increased by 10 or 1.71% compared to the previous year.
Employees
596
Change (1Y)
10
Growth (1Y)
1.71%
Revenue / Employee
$48,378
Profits / Employee
-$273,250
Market Cap
773.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABCL News
- 16 days ago - AbCellera to Participate at Upcoming Investor Conferences in May and June - Business Wire
- 21 days ago - AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 4 weeks ago - AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025 - Business Wire
- 2 months ago - AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - AbCellera Reports Full Year 2024 Business Results - Business Wire
- 2 months ago - AbCellera to Participate at Upcoming Investor Conferences in March - Business Wire
- 3 months ago - AbCellera to Report Full Year 2024 Financial Results on February 27, 2025 - Business Wire
- 3 months ago - AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology - Business Wire